KR910007536A - 외용 피부 제제 - Google Patents

외용 피부 제제 Download PDF

Info

Publication number
KR910007536A
KR910007536A KR1019900016557A KR900016557A KR910007536A KR 910007536 A KR910007536 A KR 910007536A KR 1019900016557 A KR1019900016557 A KR 1019900016557A KR 900016557 A KR900016557 A KR 900016557A KR 910007536 A KR910007536 A KR 910007536A
Authority
KR
South Korea
Prior art keywords
manganese
superoxide dismutase
containing superoxide
external
polysaccharide
Prior art date
Application number
KR1019900016557A
Other languages
English (en)
Inventor
요시오 오까야
가쓰미 도모다
다이헤이 하마자끼
Original Assignee
스즈기 쓰네시
플라가세이 고오교가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스즈기 쓰네시, 플라가세이 고오교가부시끼가이샤 filed Critical 스즈기 쓰네시
Publication of KR910007536A publication Critical patent/KR910007536A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

외용 피부 제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 필수 성분으로서, (a)망간-함유 슈퍼옥시드 디스뮤타아제 및/또는 망간-함유 슈퍼옥시드 디스뮤타아제의 폴리알킬렌 글리콜-또는 폴리사카라이드-결합변성체, 및(b) 약리학적으로 허용가능한 수용성 망간염을 함유하는 외용 피부 수성 제제.
  2. 제1항에 있어서, 상기 망간-함유 슈퍼옥시드 디스뮤타아제가 미생물로부터 얻어지는 외용 피부 수성 제제.
  3. 제1 또는 2항에 있어서, 상기 외용 피부 제제중의 상기 망간-함유 슈퍼옥시드 디스뮤타아제 및/또는 상기 망간-함유 슈퍼옥시드 디스뮤타아제의 변성체의 함량이 효능으로 환산하여 0.1∼20,000단위/g인 외용 피부 수성 제제.
  4. 제1 내지 3항중 어느 한 항에 있어서, 상기 망간염의 함량이 상기 외용 피부 제제를 기준으로 하여 0.0001∼10중량%인 외용 피부 수성 제제.
  5. 필수 성분으로서, (a)망간-함유 슈퍼옥시드 디스뮤타아제 및/또는 망간-함유 슈퍼옥시드 디스뮤타아제의 폴리알킬렌글리콜- 또는 폴리사카라이드-결합변성체, 및(b) 약리학적으로 허용가능한 수용성 망간염을 기타의 성분들과 혼합함을 특징으로 하여, 외용 피부 수성 제제를 제조하는 방법.
  6. 제5항에 있어서, 망간-함유 슈퍼옥시드 디스뮤타아제가 미생물로부터 생성되는 방법.
  7. 제5 또는 6항에 있어서, 망간-함유 슈퍼옥시드 디스뮤타아제 및/또는 망간-함유 슈퍼옥시드 디스뮤타아제의 폴리 알킬렌 글리콜-또는 폴리사카라이드-결합변성체의 혼합시에, 외용 피부 제제중에서의 그의 함량이 효능으로 환산하여 0.1∼20,000단위/g이 되도록하는 방법.
  8. 제5 내지 7항중 어느 한 항에 있어서, 망간염의 최종 생산물을 기준으로 하여 0.0001∼10중량%의 양만큼 혼합하는 방법.
  9. 수용성 망간염을 계내에 공존시킴을 특징으로 하여, 망간-함유 슈퍼옥시드 디스뮤타아제 및/또는 망간-함유 슈퍼옥시드 디스뮤타아제의 폴리알킬렌 글리콜-또는 폴리사카라이드-결합 변성체를 수성 게내에서 안정화 시키는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900016557A 1989-10-19 1990-10-17 외용 피부 제제 KR910007536A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27036389 1989-10-19
JP270363-1989 1989-10-19

Publications (1)

Publication Number Publication Date
KR910007536A true KR910007536A (ko) 1991-05-30

Family

ID=17485229

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900016557A KR910007536A (ko) 1989-10-19 1990-10-17 외용 피부 제제

Country Status (5)

Country Link
US (1) US5169630A (ko)
EP (1) EP0424033A3 (ko)
JP (1) JPH03204805A (ko)
KR (1) KR910007536A (ko)
CA (1) CA2027964A1 (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675997B1 (fr) * 1991-05-03 1993-12-24 Oreal Composition topique anti radicaux libres a base de superoxyde-dismutase et d'un derive phosphonique.
GB9110651D0 (en) * 1991-05-15 1991-07-03 Stiefel Laboratories Composition and method of enhancing sun tanning
GB9110652D0 (en) * 1991-05-15 1991-07-03 Stiefel Laboratories Composition and method of treating depigmentation disorders
CA2114240A1 (en) * 1991-08-05 1993-02-18 Sterling Drug Inc. Buffered formulation of peg-sod
US5994339A (en) * 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
US6127356A (en) * 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
AU3758695A (en) * 1994-09-20 1996-04-09 Duke University Oxidoreductase activity of manganic porphyrins
AU4606496A (en) * 1994-12-21 1996-07-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2737115B1 (fr) * 1995-07-25 1997-08-22 Oreal Composition stable contenant une enzyme
WO1999023097A1 (en) 1997-11-03 1999-05-14 Duke University Substituted porphyrins
CA2329751C (en) 1998-04-24 2010-10-12 Duke University Substituted porphyrins
DK1616869T3 (da) * 1999-01-25 2012-05-07 Nat Jewish Health Substituerede porphyriner og deres terapeutiske anvendelse
US6800292B1 (en) * 1999-04-22 2004-10-05 Howard Murad Pomegranate fruit extract compositions for treating dermatological disorders
FR2807655B1 (fr) * 2000-04-18 2005-05-20 Oreal Utilisation de sels de manganese divalent comme actifs deodorants dans les compositions cosmetiques
FR2809005B1 (fr) * 2000-05-18 2002-12-27 Oreal Utilisation du manganese dans le traitement des rides
FR2809006B1 (fr) * 2000-05-18 2002-08-02 Oreal Utilisation du manganese dans des compositions destinees a combattre la paleur de la peau
ATE439134T1 (de) * 2001-01-19 2009-08-15 Nat Jewish Med & Res Center Medikament zum schutz in der radiotherapie
AU2002312194B8 (en) * 2001-06-01 2008-05-15 Aeolus Sciences, Inc. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
WO2003103680A1 (en) * 2002-06-07 2003-12-18 Duke University Substituted porphyrins
DE102006048738A1 (de) * 2006-10-12 2008-04-17 Henkel Kgaa Oxidative Haarbehandlung mit verringerter Haarschädigung
EP2732817B1 (en) 2008-05-23 2016-08-24 National Jewish Health A compound for use in treating injury associated with exposure to phosgene or chlorine gas
EP2394670A1 (en) 2010-06-04 2011-12-14 Université de Liège Chitosan-based biomimetic scaffolds and methods for preparing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985533A (en) * 1958-06-13 1961-05-23 Grain Processing Corp Bacitracin product and processes utilizing manganese compounds
LU71110A1 (ko) * 1974-10-15 1976-11-11
JPH0196107A (ja) * 1987-10-07 1989-04-14 Kanebo Ltd 皮膚化粧料

Also Published As

Publication number Publication date
EP0424033A3 (en) 1991-07-31
CA2027964A1 (en) 1991-04-20
JPH03204805A (ja) 1991-09-06
US5169630A (en) 1992-12-08
EP0424033A2 (en) 1991-04-24

Similar Documents

Publication Publication Date Title
KR910007536A (ko) 외용 피부 제제
EP1281722A4 (en) HYALURONIC ACID GEL, METHOD FOR THE PRODUCTION THEREOF, AND THE MEDICAL MATERIAL CONTAINING GEL
CA2054189A1 (en) Stable ascorbic acid compositions
CA2256960A1 (en) High glycerin containing anti-microbial cleansers
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
GB2354167A (en) Gel cosmetic compositions
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
ATE66592T1 (de) Haarfestlegemittel.
ES8204922A1 (es) Procedimiento para la preparacion de composiciones cosmeti- cas y dermatologicas coadyuvantes en el afeitado de la piel
RU2009139896A (ru) Композиции по уходу за кожей, содержащие салициловую кислоту
KR910005876A (ko) 모세혈관 취약증의 치료를 위한 극소용 약학적 조성물
EP0208313A3 (en) Gelling agent
US4952563A (en) Waterfree application form of low molecular weight alkali huminates
DE69512430D1 (de) Herstellungsverfahren von lösungen von mehrwertigen alkoholen die schweisshemmende agentien enthalten, mit verbesserter wirksamkeit
FI962056A0 (fi) Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
HUP9902032A2 (hu) Peszticid készítmény
KR970032819A (ko) 미백화장료 조성물
CA2061870A1 (en) Medicinal compositions for use as a skin moisturizer and the treatment of exzema
CA2323690A1 (en) Liquid antimicrobial, skin moisturizing formulation
US4761278A (en) Ladies aftershave preparation and method for its manufacture
KR890007731A (ko) 생물학적으로 매우 유용한 형태의 철을 함유한 단백질 유도체, 그의 제조 및 이 화합물을 함유하는 제약 조성물
JPS6456622A (en) Percutaneous absorbefacient base composition
IE39172B1 (en) Composition having local anesthetic effect
KR950013489A (ko) 미용제 시트, 경구 미용제 및 그 제조방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid